Originally Posted by Fiona

Yes, I think the tryptamine content of mucuna would make it an issue with inhibitors so wise to tread very carefully with Azilect and deprenyl and the like. Again, we need someone inspired to help us WHo could actually have the means to figure some of this stuff out.

Even if you have already read the patent application for mucuna, I found it very worth rereading. Its information is just so beautifully clear, thorough, and, uh, informed...The writers are obviously brilliant.

http://www.freshpatents.com/Pharmace...0060165822.php